Rich countries are scrambling to reserve coronavirus vaccine doses, which means poorer countries likely won't get them

REUTERS/James Akena

• Affluent countries are spending hundreds of millions of dollars to reserve doses of COVID-19 vaccines for their citizens.
• This means poorer countries may be left waiting months to get enough doses to inoculate their citizens.
• The US, UK, France, Germany, Italy, and the Netherlands have all reserved doses of AstraZeneca's vaccine, developed by the University of Oxford.
• A counter effort is underway to ensure that vaccine makers produce enough to cover everyone at the first instance.
• The effort is led by the likes of the Bill and Melinda Gates Foundation, Red Cross, Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance.
• Visit Business Insider's homepage for more stories.

Rich nations are placing large advance orders for COVID-19 vaccines, which could mean poor countries will be left behind.

A handful of vaccine candidates have shown promising results during clinical trials, the most in-demand of which is being developed by the University of Oxford, which has partnered with pharmaceutical giant AstraZeneca. See the rest of the story at Business Insider

NOW WATCH: A cleaning expert reveals her 3-step method for cleaning your entire home quickly

See Also:

• Video shows Putin's special disinfection tunnel that people have to walk through before meeting him
• Chinese officials want Trump to win reelection because he is 'destroying US alliances' and won't unite to fight Beijing
• Fauci said US government held off promoting face masks because it knew shortages were so bad that even doctors couldn't get enough